Alta Park Capital Lp adds Dolby Laboratories (DLB) to its portfolio

Dolby Laboratories (DLB) : Alta Park Capital Lp added new position in Dolby Laboratories during the most recent quarter end. The investment management firm now holds 70,000 shares of Dolby Laboratories which is valued at $3,479,000 , the company said in a statement filed on Aug 12, 2016 with the SEC.Dolby Laboratories makes up approximately 4.86% of Alta Park Capital Lp’s portfolio.

Other Hedge Funds, Including , Cable Hill Partners sold out all of its stake in DLB during the most recent quarter. The investment firm sold 63 shares of DLB which is valued $3,131.First Mercantile Trust Co boosted its stake in DLB in the latest quarter, The investment management firm added 7,668 additional shares and now holds a total of 16,365 shares of Dolby Laboratories which is valued at $813,341. Dolby Laboratories makes up approx 0.10% of First Mercantile Trust Co’s portfolio. Solaris Asset Management added DLB to its portfolio by purchasing 100 company shares during the most recent quarter which is valued at $4,996.Msi Financial Services Inc boosted its stake in DLB in the latest quarter, The investment management firm added 199 additional shares and now holds a total of 226 shares of Dolby Laboratories which is valued at $11,291.First Quadrant L Pca reduced its stake in DLB by selling 4 shares or 0.01% in the most recent quarter. The Hedge Fund company now holds 63,116 shares of DLB which is valued at $3,114,775. Dolby Laboratories makes up approx 0.07% of First Quadrant L Pca’s portfolio.

Dolby Laboratories opened for trading at $49.86 and hit $50.04 on the upside on Monday, eventually ending the session at $49.92, with a gain of 0.10% or 0.05 points. The heightened volatility saw the trading volume jump to 3,46,157 shares. Company has a market cap of $5,040 M.

On the company’s financial health, Dolby Laboratories reported $0.76 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.66. The company had revenue of $277.60 million for the quarter, compared to analysts expectations of $268.04 million. The company’s revenue was up 19.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.49 EPS.

Many Wall Street Analysts have commented on Dolby Laboratories. Company shares were Reiterated by Dougherty & Company on Jul 28, 2016 to “Buy”, Firm has raised the Price Target to $ 57 from a previous price target of $54 .

Dolby Laboratories Inc. (Dolby Laboratories) creates audio imaging and communication technologies that transform entertainment and communications at the cinema at home at work and on mobile devices. The Company licenses its audio technologies and also develops technologies aimed at enhancing voice conferencing communications and imaging. Additionally the Company provides products and services that enable entertainment content creators and distributors to produce encode transmit and playback content for consumer experiences. The Company designs and manufactures audio and imaging products for the film production cinema and television broadcast industries. Distributed in approximately 80 countries these products are used in content creation distribution and playback to enhance image and sound quality and improve transmission and playback.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *